GENRX RIZATRIPTAN rizatriptan (as benzoate) 5 mg orally disintegrating tablets blister pack

Land: Australien

Sprache: Englisch

Quelle: Department of Health (Therapeutic Goods Administration)

Wirkstoff:

rizatriptan benzoate, Quantity: 7.265 mg (Equivalent: rizatriptan, Qty 5 mg)

Verfügbar ab:

Arrotex Pharmaceuticals Pty Ltd

INN (Internationale Bezeichnung):

rizatriptan benzoate

Darreichungsform:

Tablet, orally disintegrating

Zusammensetzung:

Excipient Ingredients: microcrystalline cellulose; magnesium stearate; mannitol; crospovidone; sucralose; Flavour

Verabreichungsweg:

Oral

Einheiten im Paket:

2

Verschreibungstyp:

(S4) Prescription Only Medicine

Anwendungsgebiete:

Rizatriptan is indicated for the acute treatment of migraine attacks with or without aura.

Produktbesonderheiten:

Visual Identification: White to off-white coloured, round-shaped tablets with "APO" engraved on one side and "RZ" over "5" on the other side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius; Container Closure: Child resistant closure

Berechtigungsstatus:

Licence status A

Berechtigungsdatum:

2016-02-09